FI41741B - - Google Patents

Info

Publication number
FI41741B
FI41741B FI0988/63A FI98863A FI41741B FI 41741 B FI41741 B FI 41741B FI 0988/63 A FI0988/63 A FI 0988/63A FI 98863 A FI98863 A FI 98863A FI 41741 B FI41741 B FI 41741B
Authority
FI
Finland
Application number
FI0988/63A
Other languages
Finnish (fi)
Inventor
D Hartley
G Hughes
H Smith
Original Assignee
H Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Smith filed Critical H Smith
Application granted granted Critical
Publication of FI41741B publication Critical patent/FI41741B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Transmission Devices (AREA)
FI0988/63A 1962-05-15 1963-05-13 FI41741B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19497262A 1962-05-15 1962-05-15

Publications (1)

Publication Number Publication Date
FI41741B true FI41741B (en:Method) 1969-10-31

Family

ID=22719572

Family Applications (1)

Application Number Title Priority Date Filing Date
FI0988/63A FI41741B (en:Method) 1962-05-15 1963-05-13

Country Status (13)

Country Link
US (1) US3502699A (en:Method)
JP (1) JPS4812737B1 (en:Method)
AT (2) AT272532B (en:Method)
BR (1) BR6349095D0 (en:Method)
CH (1) CH494213A (en:Method)
DE (3) DE1468642B1 (en:Method)
DK (2) DK116056B (en:Method)
ES (2) ES288359A1 (en:Method)
FI (1) FI41741B (en:Method)
FR (1) FR3896M (en:Method)
IT (1) IT1061776B (en:Method)
NO (2) NO124598B (en:Method)
SE (5) SE323668B (en:Method)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723533A (en) * 1968-02-27 1973-03-27 American Cyanamid Co Substituted naphthalenone and naphthalenedione compounds
DE2718872A1 (de) * 1976-06-14 1977-12-22 Jenapharm Veb Verfahren zur herstellung von neuen gona-4,9(10)-dienen
FR2618783B1 (fr) * 1987-07-30 1991-02-01 Roussel Uclaf Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
WO2015057894A1 (en) * 2013-10-15 2015-04-23 Massachusetts Institute Of Technology Methods for treating polycystic kidney disease and polycystic liver disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3069421A (en) * 1961-04-12 1962-12-18 Roussel Uclaf Process for the preparation of delta5(10)-estrene-17beta-ol-3-one and intermediates

Also Published As

Publication number Publication date
SE323669B (en:Method) 1970-05-11
DK116056B (da) 1969-12-08
FR3896M (en:Method) 1966-02-07
AT283609B (de) 1970-08-10
CH494213A (de) 1970-07-31
DE1618973C3 (de) 1974-06-06
DK114340B (da) 1969-06-23
US3502699A (en) 1970-03-24
BR6349095D0 (pt) 1973-08-02
NO124598B (en:Method) 1972-05-08
JPS4812737B1 (en:Method) 1973-04-23
DE1618973A1 (de) 1971-12-30
SE330165B (en:Method) 1970-11-09
SE330166B (en:Method) 1970-11-09
DE1793633A1 (de) 1971-12-30
DE1793633B2 (de) 1973-03-08
NO124597B (en:Method) 1972-05-08
SE323668B (en:Method) 1970-05-11
DE1468642B1 (de) 1971-03-11
IT1061776B (it) 1983-04-30
AT272532B (de) 1969-07-10
DE1618973B2 (de) 1973-10-31
ES288359A1 (es) 1963-12-01
ES288360A1 (es) 1963-12-01
DE1793633C3 (de) 1973-10-04
SE330164B (en:Method) 1970-11-09

Similar Documents

Publication Publication Date Title
FI41741B (en:Method)
BE616548R (en:Method)
BE615849A (en:Method)
BE615244A (en:Method)
BE613319A (en:Method)
BE634154A (en:Method)
BE631623A (en:Method)
BE631044A (en:Method)
BE629902A (en:Method)
BE629075A (en:Method)
BE628759A (en:Method)
BE627557A (en:Method)
BE627215A (en:Method)
BE613298A (en:Method)
BE622536A (en:Method)
BE621473A (en:Method)
BE613108A (en:Method)
BE616785A (en:Method)
BE616490A (en:Method)
BE616386A (en:Method)
BE616166A (en:Method)
BE608197A (en:Method)
BE615962A (en:Method)
BE612926A (en:Method)
BE615804A (en:Method)